The nature of transmission in prion diseases

被引:0
|
作者
Ridley, RM
Baker, HF
机构
关键词
prion; prion disease; BSE; CJD; scrapie; spongiform encephalopathy;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Replicating biological information is usually stored only within nucleic acid. The existence of 'strains' of agent in prion disease (scrapie, BSE, CTD has been taken to indicate an independent genome within the transmissible agent. Other replicable information exists, however, both in biology and elsewhere, including, for example, the 'meme' (the neural correlate of ideas which replicate in human brains by communication) and the computer virus. From this broader viewpoint, we explore the possibility that 'strain' differences in prion disease reflect biological information stored within the prion protein rather than in nucleic acid. Much of the disease variation in mice (used as evidence for strain differences) can be accounted for by the primary structures of the prion protein of the host (the experimentally infected mouse) and the donor mouse (from which infectious tissue is taken). Information determining residual disease variation (when these factors have been excluded) map reside in different conformational states of host prion protein, Prion protein can adopt different conformational and glycosylation states. The information which these states contain is only partially conserved on transmission between animals, permitting the appearance of both 'strain stability' and 'strain mutation'. Different sources of replicating, biological information including information in the 'agent' (the abnormal form of prion protein) and in the host prion gene (PRNP) are in evolutionary competition, We argue that, in the prion diseases, replicating information is not carried in nucleic acid in either the host or the 'agent' but is carried within the conformational state of the abnormal form of prion protein.
引用
收藏
页码:273 / 280
页数:8
相关论文
共 50 条
  • [21] Review: Fluid biomarkers in the human prion diseases
    Thompson, Andrew G. B.
    Mead, Simon H.
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2019, 97 : 81 - 92
  • [22] Animal prion diseases: the risks to human health
    Houston, Fiona
    Andreoletti, Olivier
    BRAIN PATHOLOGY, 2019, 29 (02) : 248 - 262
  • [23] Prospects for Preventative Vaccines Against Prion Diseases
    Sakaguchi, Suehiro
    PROTEIN AND PEPTIDE LETTERS, 2009, 16 (03) : 260 - 270
  • [24] Human Prion Diseases and the Risk of Their Transmission During Anatomical Dissection
    Bradford, Barry M.
    Piccardo, Pedro
    Ironside, James W.
    Mabbott, Neil A.
    CLINICAL ANATOMY, 2014, 27 (06) : 821 - 832
  • [25] Taking advantage of physiological proteolytic processing of the prion protein for a therapeutic perspective in prion and Alzheimer diseases
    Beland, Maxime
    Roucou, Xavier
    PRION, 2014, 8 (01) : 105 - 109
  • [26] An overview of human prion diseases
    Imran, Muhammad
    Mahmood, Saqib
    VIROLOGY JOURNAL, 2011, 8
  • [27] Prion diseases, always a threat?
    Saitoh, Yuji
    Mizusawa, Hidehiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 463
  • [28] An overview of animal prion diseases
    Muhammad Imran
    Saqib Mahmood
    Virology Journal, 8
  • [29] Organoids for modeling prion diseases
    Walters, Ryan O.
    Haigh, Cathryn L.
    CELL AND TISSUE RESEARCH, 2023, 392 (01) : 97 - 111
  • [30] Implications of prion diseases for neurosurgery
    Blättler, T
    NEUROSURGICAL REVIEW, 2002, 25 (04) : 195 - 203